APA (7th ed.) Citation

DeStefano, V. M., Wada, M., Pinz, K. G., Assi, R., Zhang, H., Wang, W., . . . Salman, H. (2024). A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma. Clinical & Translational Medicine, 14(7), 1. https://doi.org/10.1002/ctm2.1743

Chicago Style (17th ed.) Citation

DeStefano, Vincent M., et al. "A Nontandem Novel Compound Chimeric Antigen Receptor Redirected to Target CD20‐CD19 Positive B‐cell Acute Leukemias and B‐cell Lymphoma." Clinical & Translational Medicine 14, no. 7 (2024): 1. https://doi.org/10.1002/ctm2.1743.

MLA (9th ed.) Citation

DeStefano, Vincent M., et al. "A Nontandem Novel Compound Chimeric Antigen Receptor Redirected to Target CD20‐CD19 Positive B‐cell Acute Leukemias and B‐cell Lymphoma." Clinical & Translational Medicine, vol. 14, no. 7, 2024, p. 1, https://doi.org/10.1002/ctm2.1743.